{"doi":"10.3390/pharmaceutics15122761","title":"DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair","abstract":"<jats:p>DNA is an organic molecule that is highly vulnerable to chemical alterations and breaks caused by both internal and external factors. Cells possess complex and advanced mechanisms, including DNA repair, damage tolerance, cell cycle checkpoints, and cell death pathways, which together minimize the potentially harmful effects of DNA damage. However, in cancer cells, the normal DNA damage tolerance and response processes are disrupted or deregulated. This results in increased mutagenesis and genomic instability within the cancer cells, a known driver of cancer progression and therapeutic resistance. On the other hand, the inherent instability of the genome in rapidly dividing cancer cells can be exploited as a tool to kill by imposing DNA damage with radiopharmaceuticals. As the field of targeted radiopharmaceutical therapy (RPT) is rapidly growing in oncology, it is crucial to have a deep understanding of the impact of systemic radiation delivery by radiopharmaceuticals on the DNA of tumors and healthy tissues. The distribution and activation of DNA damage and repair pathways caused by RPT can be different based on the characteristics of the radioisotope and molecular target. Here we provide a comprehensive discussion of the biological effects of RPTs, with the main focus on the role of varying radioisotopes in inducing direct and indirect DNA damage and activating DNA repair pathways.</jats:p>","journal":"Pharmaceutics","year":2023,"id":624817,"datarank":0.6010999777848708,"base_score":4.007333185232471,"endowment":4.007333185232471,"self_citation_contribution":0.6010999777848708,"citation_network_contribution":0.0,"self_endowment_contribution":0.6010999777848708,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":54,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":424761,"name":"Pedram Heidari","orcid":"0000-0001-6383-465X","position":1,"is_corresponding":false},{"id":314970,"name":"Samuel J. Klempner","orcid":"0000-0002-4062-0808","position":2,"is_corresponding":false},{"id":424762,"name":"Umar Mahmood","orcid":"0000-0001-7414-6123","position":3,"is_corresponding":false},{"id":260757,"name":"Aparna R. Parikh","orcid":"0000-0002-5245-7841","position":4,"is_corresponding":false},{"id":43397,"name":"Theodore S. Hong","orcid":"0000-0001-8481-6581","position":5,"is_corresponding":false},{"id":829561,"name":"Matthew R. Strickland","orcid":"0000-0001-7845-0712","position":6,"is_corresponding":false},{"id":962565,"name":"Shadi A. Esfahani","orcid":"0000-0002-6077-4580","position":7,"is_corresponding":false},{"id":1615325,"name":"Yousef Khazaei Monfared","orcid":"0000-0002-1171-8670","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair","abstract":"<jats:p>DNA is an organic molecule that is highly vulnerable to chemical alterations and breaks caused by both internal and external factors. Cells possess complex and advanced mechanisms, including DNA repair, damage tolerance, cell cycle checkpoints, and cell death pathways, which together minimize the potentially harmful effects of DNA damage. However, in cancer cells, the normal DNA damage tolerance and response processes are disrupted or deregulated. This results in increased mutagenesis and genomic instability within the cancer cells, a known driver of cancer progression and therapeutic resistance. On the other hand, the inherent instability of the genome in rapidly dividing cancer cells can be exploited as a tool to kill by imposing DNA damage with radiopharmaceuticals. As the field of targeted radiopharmaceutical therapy (RPT) is rapidly growing in oncology, it is crucial to have a deep understanding of the impact of systemic radiation delivery by radiopharmaceuticals on the DNA of tumors and healthy tissues. The distribution and activation of DNA damage and repair pathways caused by RPT can be different based on the characteristics of the radioisotope and molecular target. Here we provide a comprehensive discussion of the biological effects of RPTs, with the main focus on the role of varying radioisotopes in inducing direct and indirect DNA damage and activating DNA repair pathways.</jats:p>","is_dataset_classified":null,"base_score":3.9889840465642745,"endowment":3.9889840465642745,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"38140100","pmcid":"PMC10748326","openalex_id":"https://openalex.org/W4389617830","authors":[],"funders":[{"funder_name":"National Cancer Institute","grant_id":"NCI K08CA259626","title":null},{"funder_name":"NCI NIH HHS","grant_id":"K08 CA259626","title":null},{"funder_name":"National Institutes of Health","grant_id":"5K08CA259626-04","title":"Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma"},{"funder_name":"National Institutes of Health","grant_id":"1K08CA273688-01","title":"Systematic liquid biopsy to monitor residual disease and treatment efficacy in gastrointestinal cancer patients"},{"funder_name":"National Institutes of Health","grant_id":"5K08CA249047-03","title":"Enhancing the therapeutic effect of receptor radionuclide therapy in neuroendocrine tumors by somatostatin receptor upregulation"}],"total_grants":5,"fwci":4.962,"citation_percentile":0.96714755,"influential_citations":0,"citation_trend":[{"year":2024,"count":7},{"year":2025,"count":25},{"year":2026,"count":21}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/1999-4923/15/12/2761/pdf?version=1702372662","host_type":"journal"},{"url":"https://www.mdpi.com/1999-4923/15/12/2761/pdf?version=1702372662","host_type":"publisher"},{"url":"https://www.mdpi.com/1999-4923/15/12/2761/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/pharmaceutics15122761","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/38140100","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10748326","host_type":"repository"},{"url":"https://doaj.org/article/80e7bf35a72b4e689356fed3aede8204","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10748326/pdf/pharmaceutics-15-02761.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC10748326","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC10748326?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.3390/pharmaceutics15122761","host_type":""}],"fields_of_study":["Cancer therapeutics and mechanisms","Radiopharmaceutical Chemistry and Applications","Radiation Therapy and Dosimetry","0301 basic medicine","0303 health sciences","03 medical and health sciences"],"mesh_terms":[],"keywords":["DNA damage","Genome instability","DNA repair","DNA","Mutagenesis","Biology","Cancer research","Cell biology","Cancer","Cancer cell","Cell cycle","DNA Damage Repair","Computational biology","Mutation","Genetics","Gene","Radioisotope","Radiopharmaceuticals","RS1-441","Pharmacy and materia medica","Review"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-04T04:57:50.625240Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}